Skip NavigationSkip to Content

Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens

  1. Author:
    Clausse, Victor
    Tao, Dingyin [ORCID]
    Debnath, Subrata
    Fang, Yuhong [ORCID]
    Tagad, Harichandra D [ORCID]
    Wang, Yuhong
    Sun, Hongmao
    LeClair, Christopher A
    Mazur, Sharlyn J [ORCID]
    Lane, Kelly
    Shi, Zhen-Dan
    Vasalatiy, Olga
    Eells, Rebecca
    Baker, Lynn K
    Henderson, Mark J [ORCID]
    Webb, Martin R
    Shen, Min [ORCID]
    Hall, Matthew D [ORCID]
    Appella, Ettore
    Appella, Daniel H
    Coussens,Nathan [ORCID]
  2. Author Address

    National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850, United States., National Center for Advancing Translational Sciences, NIH, United States., Laboratory of Cell Biology, Center for Cancer Research, NCI, NIH, United States., National Center for Advancing Translational Sciences, NIH., Imaging Probe Development Center, National Heart, Lung, and Blood Institute, NIH, United States., Reaction Biology Corporation, United States., The Francis Crick Institute, United Kingdom., Synthetic Bioactive Molecules Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, United States., Molecular Pharmacology Branch Laboratories, Frederick National Laboratory for Cancer Research, United States.,
    1. Year: 2019
    2. Date: Nov 15
    3. Epub Date: 2019 09 03
  1. Journal: The Journal of biological chemistry
    1. 294
    2. 46
    3. Pages: 17654-17668
  2. Type of Article: Article
  3. ISSN: 0021-9258
  1. Abstract:

    Wildtype P53-induced phosphatase 1 (WIP1) is a member of the magnesium-dependent serine/threonine protein phosphatase (PPM) family and is induced by P53 in response to DNA damage. In several human cancers, the WIP1 protein is overexpressed, which is generally associated with a worse prognosis. Although WIP1 is an attractive therapeutic target, no potent, selective, and bioactive small-molecule modulator with favorable pharmacokinetics has been reported. Phosphatase enzymes are among the most challenging targets for small molecules because of the difficulty of achieving both modulator selectivity and bioavailability. Another major obstacle has been the availability of robust and physiologically relevant phosphatase assays that are suitable for high-throughput screening. Here, we describe orthogonal biochemical WIP1 activity assays that utilize phosphopeptides from native WIP1 substrates. We optimized an MS assay to quantify the enzymatically dephosphorylated peptide reaction product in a 384-well format. Additionally, a red-shifted fluorescence assay was optimized in a 1,536-well format to enable real-time WIP1 activity measurements through the detection of the orthogonal reaction product, inorganic phosphate. We validated these two optimized assays by quantitative high-throughput screening against the National Center for Advancing Translational Sciences (NCATS) Pharmaceutical Collection and used secondary assays to confirm and evaluate inhibitors identified in the primary screen. Five inhibitors were further tested with an orthogonal WIP1 activity assay and surface plasmon resonance binding studies. Our results validate the application of miniaturized physiologically relevant and orthogonal WIP1 activity assays to discover small-molecule modulators from high-throughput screens. Published under license by The American Society for Biochemistry and Molecular Biology, Inc.

    See More

External Sources

  1. DOI: 10.1074/jbc.RA119.010201
  2. PMID: 31481464
  3. PMCID: PMC6873202
  4. WOS: 000503173500038
  5. PII : RA119.010201

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel